BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/68/0.1/20.12.24 | Market Closed - Börse Stuttgart 02:44:34 2024-07-05 am EDT | ||
| 0.075 EUR | -2.60% |
|
| Current month | +19.05% | ||
| 1 month | -31.82% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 0.075 | -2.60% |
| 24-07-04 | 0.077 | +14.93% |
| 24-07-03 | 0.067 | -28.72% |
| 24-07-02 | 0.094 | +38.24% |
| 24-07-01 | 0.068 | +7.94% |
Delayed Quote Börse Stuttgart
Last update July 05, 2024 at 02:44 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VD4BB3 |
| ISIN | DE000VD4BB31 |
| Date issued | 2024-04-16 |
| Strike | 68 $ |
| Maturity | 2024-12-20 (167 Days) |
| Parity | 10 : 1 |
| Emission price | 0.17 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.228 € |
|---|---|
| Lowest since issue | 0.063 € |
| Spread | 0.01 € |
| Spread % | 12.50% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
92.32
USD
Average target price
96.13
USD
Spread / Average Target
+4.12%
- Stock Market
- Warrants
- Warrant
